Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...
Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress ...
News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
Irish Independent on MSN
Innovative therapy gives hope to patients whose blood cancer ‘seemed incurable’
Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now ...
A collaborative study led by biomedical researchers Chris Lengner and M. Andrés Blanco at the School of Veterinary Medicine at the University of Pennsylvania has identified two genes that suppress ...
When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
A Leicester teen is “really well” after being the first to receive a pioneering blood cancer treatment. Alyssa Tapley was ...
New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in cancer and identified cancer-driving mutations in an underexplored part of ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback